Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
Cancer Drug Development
Economic issues Yabroff, et al. (2004) cited data from 2000 National Health Survey in which data from 1823 cancer survivors was tracked. Results showed that the burden of illness from cancer was significant in many life-areas of patients such as summary measure of health, days lost from work, and health utility lost.
Special health needs
Process (decision, steps) involved in program
Benefits of program
Cancer is amongst fatal diseases that involve abnormal growth of body cells resulting is unusual growth and division of cells. The result is tumor formation effecting one particular or many parts of the body. Since there is high probability of cancer cells invading the neighboring tissues of body parts, early detection and careful treatment of cancer is deemed absolutely necessary. The treatment is not only costly but involves multi-stage radiation treatments (Castro, 2001). More than 13% of human deaths world over are caused by cancer related diseases. Since the treatment of cancer diseases is costly throughout the world, new drug development also involves multi-million R&D on cancer drugs. Series of rigorous tests are conducted in laboratories before cancer drugs are approved for being administered to patients. Drug development process involves preclinical and translational work. This white paper is aimed at presenting major issues in cancer drugs including economic issues, special needs of specific population being served, process and steps involved in program, and benefits of drug treatment program. Visuals will also be added in this paper to help brief the potential patients regarding the drug treatment process.
Cancer Drug development
Thesis statement
New drug development for cancer involves multi-million R&D investments. On the other hand, patient cost for obtaining cancer treatment is also high and includes multi-stage difficult treatments. To help aid this process, our company has developed a new cancer treatment drug that will be administered through a need-based treatment program implementation. This will help address the economic issues of patients requiring cancer treatment; will serve special needs of intervention population, and provide specific health benefits to participant patients.
Economic issues
The patients loose productivity as they are rendered immobile due to cancer treatment. Days lost from work were reported to be 65 out of 260. Self rated health status of cancer patients was also less as compared to non-cancer patients. In all cancer types i.e. prostate, colorectal, lungs, and breast cancer, worst health outcomes results in increased expenditure on health. Additional use of health services also severs the mobility of cancer patients and also reduces their economic prospects due to continued treatments.
Caregiver burden is also involved when treating cancer patients. Loss of work on part of caregiver is also an economic loss and continued absence from work is mandated for caring the cancer patients. The cost of illness for cancer patients is both direct and indirect. Phase-specific cost of treatment along with long-term economic expenses is also part of cancer treatment. The most effected group of cancer patients was observed to be one having being diagnosed the diseases recently. The new diagnoses reduced the number of working days significantly.
Special health needs
Cancer patients have special health needs to be met at regular intervals. McIllmurray, et al. (2007) reported that there are several health needs of cancer patients that are different from other ailments. The patients require assistance from healthcare professionals as well as information regarding their recovery and health. Support network of friends, family, and other social acquaintances is also required.
Some of the most special needs of patients are identity crisis management whereby patients…
References
Castro, J.B.D. (2001). Cancer: Cause, Care & Cure. B. Jain Publishers.
Elwyn, G., O'Connor, A., Stacey, D., Volk, R., Edwards, A., Coulter, A., ... & Whelan, T. (2006). Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Bmj, 333(7565), 417.
Helixor. (2013). Integrative Cancer Therapy. Retrieved from: [http://www.helixor.com/site.php?mainkat=02&subkat=01&id=22]
McIllmurray, M.B., Thomas, C., Francis, B., Morris, S., Soothill, K., & AL-HAMAD, A. (2001). The psychosocial needs of cancer patients: findings from an observational study. European Journal of Cancer Care, 10(4), 261-269.
Figure 1 portrays the state of Maryland, the location for the focus of this DRP. Figure 1: Map of Maryland, the State (Google Maps, 2009) 1.3 Study Structure Organization of the Study The following five chapters constitute the body of Chapter I: Introduction Chapter II: Review of the Literature Chapter III: Methods and Results Chapter IV: Chapter V: Conclusions, Recommendations, and Implications Chapter I: Introduction During Chapter I, the researcher presents this study's focus, as it relates to the
Lack of accountability, transparency and integrity, ineffectiveness, inefficiency and unresponsiveness to human development remain problematic (UNDP). Poverty remains endemic in most Gulf States with health care and opportunities for quality education poor or unavailable, degraded habitats including urban pollution and poor soil conditions from inappropriate farming practices. Social safety nets are also entirely inadequate and all form part of the nexus of poverty that is widely prevalent in Gulf countries.
Health Disparity Health disparities refer to a certain kind of health-related difference closely tied to economic or social disadvantage. They negatively impact groups of individuals systematically subject to greater economic and social barriers to a hygienic environment and health, on the basis of their ethnic or racial group, age, gender, religion, mental health, socioeconomic standing, geographic location, gender identity or sexual orientation, physical, cognitive, or sensory disability, or any other characteristics
" (AAFP, nd) The Health Maintenance Organization further should "…negotiate with both public and private payers for adequate reimbursement or direct payment to cover the expenses of interpreter services so that they can establish services without burdening physicians…" and the private industry should be "…engaged by medical organizations, including the AAFP, and patient advocacy groups to consider innovative ways to provide interpreter services to both employees and the medically underserved." (AAFP,
Prescription weight loss pills are diet drugs, regulated by the Food and Drug Administration. If certain side effects exist, then they are advertised and prescribed for weight loss only under certain criteria and in certain pill-dosages. Examples of prescription diet pills include Merida and Phentermine, and these types of diet pills are principally designed for those suffering from serious obesity. Diet and weight loss prescription drugs are not a
Health Promotion: American HIV Prevention in an Era of False Security - an Investigative Study AIDS is one of the most dangerous diseases to affect humankind. AIDS awareness is best-funded and best-taught in the United States of America. This realization is especially apparent when HIV rates are examined in African countries and some Asian countries such as India. Education levels about sexually transmitted diseases in general - and funding for prevention and